Invesaro

Stocks Real estate GBCS

OTC · Real estate

Selectis Health, Inc. (GBCS)

Selectis Health, Inc. brought in $32.5M of revenue over the twelve months to June 30, 2026, down 21.3% from a year earlier. Net income was $14.6M, a net margin of 44.9%. Operating cash flow minus capital spending left $1.4M of free cash flow in fiscal 2025. At June 30, 2026 it held $7.7M in cash against $17M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 24, 2026.

Watch GBCS in 60 seconds
Price
$5.72
-0.18% on the day · September 28, 2026
52-week range $1.50 to $5.83
Market cap
$17.5M
Revenue (last 12 months)
$32.5M
-21.3% year on year
Net margin
44.9%

What Selectis Health, Inc. does

Selectis Health, Inc. is registered with the SEC under industry code SIC 6798 (Real Estate Investment Trusts). Its shares trade on OTC under the ticker GBCS.

Revenue and profit by year

Revenue
FY18: $3.6M $3.6M FY18FY19: $6.9M $6.9M FY19FY20: $20.9M $20.9M FY20FY21: $29.3M $29.3M FY21FY22: $40.6M $40.6M FY22FY23: $36.8M $36.8M FY23FY24: $39.5M $39.5M FY24FY25: $41.4M $41.4M FY25
Net income
FY18: -$2M -$2M FY18FY19: -$861.6K -$861.6K FY19FY20: $3M $3M FY20FY21: -$2.3M -$2.3M FY21FY22: -$2.4M -$2.4M FY22FY23: -$4M -$4M FY23FY24: -$2.4M -$2.4M FY24FY25: -$1M -$1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$41.4M-$1.6M-$1M-$0.34$1.4M
2024$39.5M-$2.7M-$2.4M-$0.80-$1.9M
2023$36.8M-$9M-$4M-$1.31$506.9K
2022$40.6M-$286.6K-$2.4M-$0.79-$527.5K
2021$29.3M-$729K-$2.3M-$0.82-$790.5K
2020$20.9M$3.4M$3M$0.95$1.7M

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 14, 2025. Not a date the company has announced. See the report calendar

Where GBCS ranks in Real estate

Revenue$41.4M
#178 of 230 in Real estate · Bottom 23%
Revenue growth+4.9%
#95 of 205 in Real estate · Top 46%
Net margin-2.5%
#145 of 208 in Real estate · Bottom 30%
Free cash flow margin3.5%
#82 of 116 in Real estate · Bottom 30%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Real estate

Dividends

It paid out $440.8K in cash dividends.

Fiscal yearPer sharePaid outOf profit
2015n/a$440.8Kn/a
2014n/a$414.6Kn/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Selectis Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 9, 2026
  2. September 8, 2026
  3. August 31, 2026
  4. August 25, 2026
  5. August 24, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 55% to $4.7M versus the same quarter last year; diluted EPS $2.35 versus -$0.10.
  6. August 18, 2026
  7. August 18, 2026
  8. August 11, 2026
  9. August 3, 2026
  10. July 16, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on May 26, 2026. Insider transactions on SEC

What is GBCS worth? A DCF from its reported cash flow

Insider trades

What the people running Selectis Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
December 18, 2025 Baller LanceDirector, 10% owner Boughtindirect 6,192 $2.20 $13.6K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns GBCS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 52,808 shares in total, about $302.1K at the last price.

HolderSharesAs of
Baller LanceDirector, 10% owner 52,80852,808 held indirectly December 18, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about GBCS

What does Selectis Health, Inc. do?

Selectis Health, Inc. is registered with the SEC under industry code SIC 6798 (Real Estate Investment Trusts). Its shares trade on OTC under the ticker GBCS.

Is Selectis Health, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $14.6M on revenue of $32.5M, a net margin of 44.9%.

How much revenue does Selectis Health, Inc. make?

Over the twelve months to June 30, 2026 Selectis Health, Inc. reported revenue of $32.5M. That is 21.3% less than a year earlier.

When did Selectis Health, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 24, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the change in control from September 9, 2026.

Similar companies

Compare GBCS with

Compare GBCS with any company

Follow GBCS

Get an email when Selectis Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow GBCS: get an email when it files

Where the numbers come from

Financial figures are the values Selectis Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.